DNA RNA and Cells
31 January 2013
Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors30 January 2013
RXi Pharmaceuticals Announces Completion of Enrollment in Second Phase 1 Trial for RXI-109 Program30 January 2013
Mesoblast Receives FDA Clearance for Phase 2 Clinical Trial of Mesenchymal Precursor Cells in Patients With Active Rheumatoid Arthritis28 January 2013
Oncolytics Biotech® Inc. Announces Positive REOLYSIN Clinical Trial Data Presented at ASCO Gastrointestinal Cancers Symposium23 January 2013
Mirna Therapeutics Presents Preclinical Data on Lead Product Candidate MRX34 at Keystone Conference11 January 2013
MESOBLAST’S NEOFUSE STEM CELL PRODUCT SHOWS POSITIVE RESULTS IN PHASE 2 LUMBAR SPINAL FUSION TRIAL10 January 2013
BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia in EuropeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports